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Background: Although insulin-like 3 (INSL3) has been identified in the gonad of both sexes in many species, there
are only limited reports on the distribution of INSL3 and its receptor, relaxin/insulin-like family peptide receptor 2
(RXFP2), in the primate ovary. Since the hormone-receptor pair is believed to play a role in female reproduction,
investigating the transcription of INSL3/RXFP2 genes and the spatiotemporal expression of INSL3 in the nonhuman
primate may shed light on the functional aspects of the system in humans.
Methods: Database mining, molecular and immunological methods were applied.
Results: One single INSL3 transcript and three novel splice variant transcripts of RXFP2 were identified in the ovary
of rhesus macaques. While the full-length RXFP2 transcript is barely detectable in granulosa cells during the
periovulatory period, INSL3 transcript and protein are highly abundant in theca cells surrounding antral follicles.
Moreover, the INSL3 level in follicular fluid is 3-4 times higher than that in female serum which remains low
throughout the menstrual cycle.
Conclusions: The presence of INSL3 and its receptor in the ovary implies a potential role of the ligand-receptor
pair in female reproduction in nonhuman primates. However, the existence of multiple splice variants of RXFP2
indicates a very complex nature of the hormone-receptor system.
Background
Insulin-like 3 (INSL3), also known as Leydig cell insulin-
like peptide (Ley-IL) and relaxin-like factor (RLF), was
originally discovered in the porcine during a search for
testis-specific genes [1]. Closely related to relaxin,
INSL3 peptide is a heterodimer of A and B peptides
linked by disulphide bonds. In mice, deletion of INSL3
leads to bilateral intra-abdominal cryptorchidism in
males due to defects in gubernacular differentiation, and
reduced fertility in females due to disrupted estrous
cycles [2]. Later studies also revealed that INSL3 pro-
moted oocyte maturation independent of the mid-cycle
luteinizing hormone (LH) surge in the ovary, and sup-
pressed germ cell apoptosis in the testis in rodents [3].
Relaxin/insulin-like family peptide receptor 2 (RXFP2),
also known as Leucine-rich G protein-coupled receptor
8 (LGR8) or G protein-coupled receptor affecting testis
descent (GREAT), is believed to be the sole receptor for
INSL3 as mice lacking RXFP2 exhibit the same testicu-
lar phenotype as that of Insl3 knockout mice [4,5].
Although decreased blood INSL3 levels and mutations
in Insl3/RXFP2 genes have been linked to a small num-
ber of human cryptorchidism cases [6-10], functions of
the INSL3-RXFP2 system in species other than mice are
largely unknown.
Expression of the INSL3-RXFP2 system has been
detected in many mammalian species including rodents,
domestic and wild animals as well as primates [11-17].
The relatively high circulating INSL3 levels in male
rodents and men indicate a substantial role of INSL3 as
a sex-linked endocrine factor; however, the serum
INSL3 levels in females are much lower [18].
In the present study we report the identification and
expression of the INSL3-RXFP2 system in a nonhuman
primate species, the rhesus macaque. Taking molecular
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que INSL3 and RXFP2 transcripts and splice variants in
the ovary of rhesus monkeys, and investigated the tissue
and cellular localization of INSL3 at both mRNA and
protein levels. Due to the close resemblance of repro-
ductive physiology between macaque species and
humans, these findings may provide insights into the
functional significance of the INSL3-RXFP2 signalling
pathway in human female fertility.
Methods
Animals and tissue collection
Macaque tissues were collected from adult rhesus mon-
keys between 5 and 15 years of age through a tissue dis-
tribution program provided by the Division of Animal
Resources (DAR) at the Oregon National Primate
Research Center (ONPRC). All animal protocols and
procedures were approved by the Institutional Animal
Care and Use Committee (IACUC) of Oregon Health &
Science University (OHSU) and were conducted in
accordance with the National Institute of Health’s Guide
for the Care and Use of Laboratory Animals.
Database mining, 5’-rapid amplification of cDNA ends (5’-
RACE) and amplification of RXFP2 splice variants
Human INSL3 mRNA sequence (NM_005543) was used
to search a rhesus macaque genome database [19] and a
non-human, non-mouse expressed sequence tag (EST)
database [20] for the macaque INSL3 homologue, and
gene-specific primers (Table 1) were designed to amplify
the entire INSL3 mRNA sequence from a monkey testis
cDNA pool. Using a predicted macaque RXFP2 mRNA
sequence (XM_001118169.1) as template, we designed a
specific primer (Table 1) to amplify the 5’-end of RXFP2
from the macaque uterus. 5’-RACE-ready cDNA was
generated following the protocol provided by the
SMART RACE cDNA Amplification Kit (Clontech,
Moutain View, CA, USA). The exon-intron boundaries
in macaque RXFP2 mRNA were determined by align-
ment with the human RXFP2 mRNA sequence using
Vector NTI software (Invitrogen, Carlsbad, CA, USA).
Macaque RXFP2-specific primers (Table 1) spanning
exons 6 to 17 were designed to amplify macaque RXFP2
coding sequence from macaque uterus and ovary
RACE-ready cDNA pools. PCR was performed for 40
cycles with Phusion high-fidelity DNA polymerase (New
England Biolabs Inc., Ipswich, MA, USA) in a DNA
Engine thermal cycler (Bio-Rad Laboratories, Hercules,
CA, USA). The PCR amplicons were cloned into the
PCR cloning vector pGEMT (Promega, Madison, WI,
USA) and subjected to DNA sequencing.
Collection of macaque oocytes, granulosa cells, and theca
cells
For oocyte and granulosa cell collection, the controlled
ovarian stimulation (COS) protocol, follicular aspiration,
and oocyte collection procedures were performed as
previously reported [21,22]. Human chorionic gonado-
tropin (hCG) was administered as a LH mimic to initi-
ate periovulatory events. Aspirated follicular fluid
containing granulosa cells (GC) were filtered through a
70-μm cell strainer (Becton Dickinson Labware, Franklin
Lakes, NJ, USA) and precipitated at low speed. GC were
recovered through low-speed centrifugation in 40% per-
coll/Hanks balanced salt solution (HBSS) (Invitrogen).
GC obtained from antral follicles prior to hCG treat-
ment were considered non-luteinized GC (NLGC), while
those collected after hCG administration were consid-
ered luteinized GC (LGC). Theca cells were collected
from frozen monkey ovarian sections using a PixCell II
(Arcturus, Sunnyvale, CA, USA) laser capture microdis-
section system following the manufacturer’s protocol.
Table 1 Primers used for RT-PCR amplification of INSL3, RXFP2 and PPIA
Gene Name GenBank Acc. No. Primer Sequence TA
INSL3 HM102325 RT-PCR primers: 60°C
Forward: 5’- ATAAGTTGTGCGGCCACCAC
Reverse: 5’- TTTATGGTGCTGTGTGGCCTC





Primers spanning from exons 6 to 17:
Forward: 5’-TGCATTAGACACATATCCAGG-3’
Reverse: 5’- ACTGAGGTCTGCCGTTTTC-3’
PPIA (Cyclophilin A) BC137058.1 Forward: 5’-GCTGGACCCAACACAAATG 56°C
Reverse: 5’-TCTTCTTGCTGGTCTTGCC
TA: annealing temperature
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Total RNA was extracted from monkey tissues and
granulosa cells using Trizol reagent (Invitrogen), and
from monkey oocytes and laser captured theca cells
using Absolutely RNA Nanoprep Kit (Stratagene, La
Jolla, CA, USA) following the recommended manufac-
turers’ protocols. The integrity of total RNA was
assessed using an Agilent 2100 Bioanalyzer (Agilent
Technologies Inc., Santa Clara, CA, USA). Total RNA
was then treated with RNase-free DNase (Promega,
Madison, WI, USA) and reverse-transcribed into cDNA
with Oligo (dT)12-18 primers and Superscript III Reverse
Transcriptase (Invitrogen). RT-PCR primer pairs and
corresponding annealing temperatures are listed in
Table 1. PCR was performed with HotstarTaq DNA
polymerase (Qiagen, Valencia, CA, USA) and all PCR
products were verified by DNA sequencing. PPIA (Pepti-
dylProlyl Isomerase A, also known as cyclophilin A)
served as an internal control.
Selected macaque INSL3 and RXFP2 amplicons
obtained by RT-PCR were cloned into the pGEMT vec-
tor (Promega). Monkey ovaries and testes were fixed in
4% paraformaldehyde, embedded in paraffin, and sec-
tioned at 5-μmi n t e r v a l s .a-
35S-UTP-labeled antisense
and sense probes were generated by the Riboprobe T7/
SP6 combination systems (Promega). Hybridization was
carried out as previously described [23,24]. The paraffin
sections hybridized with a-
35S-UTP-labeled sense probe
were used as a negative control.
Protein extraction and Western blot
Macaque tissue total protein was extracted using 1×
RIPA buffer (50 mM Tris-HCl pH7.4, 150 mM NaCl, 2
mM EDTA, 1% NP-40, 0.1% SDS) containing 1× Com-
plete Protease Inhibitor Cocktail (Roche, Basel, Switzer-
land). Eighty μg of total protein in 1× Laemmli sample
buffer (Bio-Rad Laboratories) was heated at 85°C for 5
minutes and then cooled to room temperature before
being separated on a precast 4-20% polyacrylamide Tris-
HCl gel (Bio-Rad Laboratories). The protein was trans-
ferred onto a PVDF membrane (Millipore, Billerica, MA,
USA). The membrane with immobilized protein was
blocked with StartingBlock T20 (TBS) Blocking Buffer
(Pierce, Rockford, IL, USA) first, and then blotted with a
rabbit anti-INSL3 antibody (ab65981, Abcam, Cam-
bridge, MA, USA) at a 1:1,000 dilution. HRP-conjugated
anti-rabbit IgG (Santa Cruz Biotechnology) was used as
secondary antibody at a 1:10,000 dilution. Following a 5-
minute incubation with ECL Western blotting substrate
(Millipore), the signal was visualized on a Kodak Biomax
light film (Kodak, Tokyo, Japan). The size of the
detected protein band was determined by the PageRu-
ler™ Plus Prestained Protein Ladder (Fermantas Interna-
tional Inc., Burlington, Ontario, Canada) separated on
the same gel. The same membrane was stripped and
re-blotted with HRP-conjugated mouse monoclonal
beta-ACTIN (ab20272, Abcam) antibody (1:8,000 dilu-
tion), which served as an internal loading control.
Immunohistochemistry (IHC)
Macaque ovary paraffin sections at 5-μmt h i c k n e s s
were used for IHC. Before incubating with a rabbit
anti-INSL3 antibody (H-035-48, Phoenix Pharmaceuti-
cals, Burlingame, CA) which recognizes INSL3 precur-
sor, the ovarian sections were deparaffinised, hydrated,
and blocked with a universal blocking reagent named
CAS BLOCK™(Invitrogen). IHC was performed with
EnVision™dual link HRP (DAB+) kit (Dako, Carpin-
teria, CA, USA) according to the manufacturer’sm a n -
ual. The INSL3 antibody was diluted at 1:2,000, and
the sections were counterstained with hematoxylin.
Normal rabbit serum-stained sections were used as a
negative control.
Radioimmunoassay (RIA)
Individual macaque blood andf o l l i c u l a rf l u i ds a m p l e s
were collected from 3-4 different monkeys and mea-
sured separately for INSL3 level with an INSL3
(human)-RIA kit (Phoenix Pharmaceuticals) following
the manufacturer’s protocol. The kit has a standard
range of 10-1280 pg/ml with a minimum detectable
range of 20.17 pg/ml. The intra- and inter-assay coeffi-
cient of variation is 5-7% and 12-15%, respectively.
Female serum at follicular phase was collected from day
1 to day 14 of the menstrual cycle, while luteal phase
serum was collected from day 15 to day 28 of the cycle.
Follicular fluid was collected from preovulatory follicles
during COS protocols [21]. Follicular aspiration was
performed in animals at day 8 of COS protocols prior
to hCG treatment (0 h) and at 36 hrs post hCG (36 h).
The values are presented as mean ± SE (standard error).
All experiments described above were replicated at
least three times with biological samples derived from
different animals. Tissues and cells collected from each
animal were assayed individually.
Results
Identification of INSL3 and RXFP2 transcripts in rhesus
macaques
A full-length macaque INSL3 mRNA sequence without
t h ep o l y ( A )t a i lw a sa m p l i f i e df r o mt h em o n k e yt e s t i s
cDNA pool and deposited in the GenBank database [25]
with accession number HM102325. The macaque INSL3
homologue comprises 2 exons and shares ~93% identity
with its human counterpart at the nucleotide level. The
deduced macaque INSL3 precursor protein is composed
of 131 amino acids which are ~90% identical with that
in human INSL3 (NP_005534.2).
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by 5’-RACE with cDNA derived from the macaque
uterus (GU326354), and the protein deduced from
RXFP2 coding region shares 96% identity with human
RXFP2 protein (NP_570718.1). Macaque RXFP2
mRNA consists of 18 exons. To demonstrate whether
RXFP2 splice variants exist in female reproductive sys-
tem of rhesus macaques, we amplified exons 6 to 17 in
the ovary and uterus by RT-PCR (Figure 1a). To our
surprise, besides the full-length transcript at ~1.1 kb,
three distinctive splice variants were also amplified
from both tissues: RXFP2-sv1 is 877 bp long with exon
15 missing; RXFP2-sv2 is 808 bp and lacks both exons
11 and 15; and the shortest splice variant, RXFP2-sv3
(738 bp), has deleted exons 8, 11 and 15 (Figure 1b).
The GenBank accession numbers for three spliced
transcripts are GU326355, GU326356 and GU326357,
respectively.
Distribution of INSL3-RXFP2 transcripts in rhesus
macaques
Macaque INSL3-specific primers spanning both exons
were used to amplify INSL3 transcripts from 14 maca-
que tissues. A cDNA fragment corresponding to 94-482
bp of macaque INSL3 mRNA was detectable mainly in
the hypothalamus, ovary, pituitary and testis, with rela-
tively higher abundance in the ovary and testis (Figure
2a). Macaque RXFP2-specific primers were designed to
amplify the RXFP2 mRNA sequence between exons 11
and 15 so that only full-length transcript would be
amplified. The full-length RXFP2 mRNA appears to be
mainly expressed in the ovary and uterus, and weakly
detectable in the hypothalamus and several other
somatic tissues (Figure 2a).
The transcription of INSL3-RXFP2 was also examined
in different cell populations in the ovary by RT-PCR
(Figure 2b). Whereas INSL3 transcript was only detected
Figure 1 Identification of RXFP2 splice variants in the ovary (Ov) and uterus (Ut). a. Agrose gel (1%) electrophoresis of PCR amplicons from
both tissues. One kb Plus DNA Ladder (MM, molecular marker) (Invitrogen) was used as marker, and PPIA was used as an internal control. DNA
was stained with ethidium bromide. The experiment was repeated with ovary and uterus cDNA derived from three monkeys; b. Simplified
schematic representation of RXFP2 exons, transcripts and their corresponding encoding RXFP2 protein regions. LDLa, Low Density Lipoprotein
Receptor Class A domain; LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily; 7tm_1, 7 transmembrane receptor; ATG,
translation start codon; TAG, translation stop codon.
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RXFP2 is expressed only in granulosa cells including
both nonluteinized (NLGC) and luteinized granulosa
cells (LGC). The experiment was repeated with oocytes
of various stages (e.g., germinal vesicle intact, metaphase
I and metaphase II) and ovarian somatic cells derived
from multiple animals, and the full-length RXFP2 tran-
script was never amplified from either oocytes or thecal
cells.
Consistent with the RT-PCR result, in situ hybridiza-
tion detected abundant expression of INSL3 mRNA in
the theca layers surrounding antral follicles, but not
those surrounding secondary follicles (Figure 2c).
Weak signals were also visible in corpora lutea. No sig-
nal above background was observed in either oocytes
or granulosa cells. Despite RT-PCR amplification in
the ovary, no specific RXFP2 signal was detected by in
situ hybridization with multiple probes targeting differ-
ent regions of RXFP2 mRNA, possibly due to a very
low level expression of RXFP2 transcript in individual
cells.
Expression of INSL3 protein in the macaque ovary
Using an antibody raised against human INSL3 precur-
sor, an approximately 14.5 kDa band was detected in
the macaque ovary, testis and pituitary (Figure 3a). The
size of macaque INSL3 is identical to that of mouse
(not shown). IHC detected specific staining of INSL3
antibody only in the theca layers surrounding antral fol-
l i c l e si nt h eo v a r y( F i g u r e3 b ) .S i n c eo n l yp a r to fe a c h
macaque tissue was used for protein extraction and
Western blot, quantitative analysis of the Western blot
was not performed due to the uneven distribution of
INSL3-expressing follicles in the ovary.
Figure 2 Detection of INSL3 and RXFP2 transcripts in rhesus macaques. a. Tissue distribution of INSL3-RXFP2 in the rhesus macaque. Total
RNA extracted from the brain cortex (Br), heart (He), hypothalamus (Hyp), kidney (Ki), liver (Li), lung (Lu), ovary (Ov), oviduct (Ovi), pituitary (Pit),
skeleton muscle (Sk), spleen (Sp), testis (Te), thymus (Thy) and uterus (Ut) were subjected to RT-PCR. b. Cellular expression of INSL3-RXFP2 in the
macaque ovary. GV: germinal vesicle-intact oocytes; MI, MII: metaphase I, II oocytes; NLGC, LGC: non-luteinized, luteinized granulosa cells; The:
Theca cells. PPIA was used as an internal control and 1 kb plus DNA ladder (Invitrogen) was used as molecular marker (MM) in both cases. c. In
situ hybridization of INSL3 in the monkey ovary. White arrowheads denote theca layers of antral follicles. SF, secondary follicle; EAF: early antral
follicle; AF: antral follicle; CL: corpora luteum; BF: bright field; DF: dark field. All experimental samples were collected from at least 3 individual
animals.
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in macaques
Using a highly sensitive RIA kit, we measured the
INSL3 levels in adult female monkey sera during nat-
ural menstrual cycles and in follicular fluid collected
during COS protocols [21]. The levels of INSL3 in the
serum and follicular fluid are shown in Figure 3c.
Throughout the entire menstrual cycle, there is no
dramatic fluctuation of INSL3 levels in the female
serum. On average, the serum INSL3 level in females
(120.26 ± 7.37 pg/ml) is less than 1/3 of that in males
(435.3 ± 125.6 pg/ml). However, INSL3 levels are sub-
stantially higher in the follicular fluid during the preo-
vulatory period: 1027.78 ± 55.0 pg/ml prior to hCG
treatment (0 h) and 592.59 ± 54.56 pg/ml prior to ovu-
lation (36 h post hCG).
Figure 3 INSL3 protein expression in selected macaque tissues. a. Western blot analysis of INSL3 in selected endocrine-reproductive tissues.
Eighty μg of total protein isolated from the ovary (Ov), testis (Te), hypothalamus (Hyp) and pituitary (Pit) was loaded in each lane. b-ACTIN (~47
kDa) was used as an internal loading control, and PageRuler™ Plus Prestained Protein Ladder (Fermentas) was used as molecular weight marker
(MW). b. Immunohistochemistry (IHC) detection of INSL3 protein in the macaque ovary. Positive signal (brown) of INSL3 was localized in the
thecal cells (The) surroundingantral follicles (AF), but not in other cell types within the ovary (A, B). Normal rabbit serum stained ovary section
was used as negative control (C). GC, granulosa cells. c. INSL3 levels in monkey sera and follicular fluid during controlled ovarian stimulation
(COS) protocols at 0-h and 36-h post hCG treatment. F serum follicular, female serum at follicular phase; F serum luteal, female serum at luteal
phase; M, male. The value is presented as mean ± SE. Tissue lysate, sections, blood and follicular fluid were isolated from 3-4 different animals.
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Nonhuman primates exhibit reproductive physiology
that is similar to humans. For example, female rhesus
macaques have 28-day mono-ovular menstrual cycles
that closely resemble women’s reproductive cycles, and
utilize the LH-chorionic gonadotropin (CG) endocrine
system unique to higher primates and absent in lower
primates and nonprimates [26]. Thus, nonhuman pri-
mates are the most relevant models for studies of
human reproduction. Previous studies have shown that
INSL3 is more likely to have a functional endocrine role
in males than in females as the blood level of INSL3 in
males is significantly higher than that in females [27].
Our data demonstrates that INSL3 is also relatively
enriched in the ovary of macaques, and the transcript of
its full-length receptor can be detected in the ovary. The
localization of the ligand to the theca layer and receptor
to the granulosa cells suggests a potential local regula-
tory (paracrine) role of INSL3 in follicle maturation in
nonhuman primates.
The structure and expression of INSL3-RXFP2 have
been studied in primates in a limited manner. Previously
an alternative splicing of INSL3, which possesses an
extra exon (exon 1A) between exons 1 and 2, has been
reported in marmoset monkeys [17] and humans
(AY082014.1). Our data suggest that this particular
splice variant of INSL3 does not exist in rhesus maca-
ques for the primers spanning both exons consistently
amplified one single transcript from different tissues
derived from several monkeys. INSL3 mRNA has been
detected in various mammalian tissues, mostly only by
highly sensitive RT-PCR. In the marmoset monkey,
INSL3 transcript was only identified in the testis by
Northern blot and the ovarian corpora lutea by RT-PCR
[17]. Besides the ovary and testis, we also detected
INSL3 mRNA in the hypothalamus and pituitary in the
macaque. The hypothalamic expression of INSL3 tran-
script is consistent with a previous report in the cow,
but has not been observed in rodents [28]. However, an
antibody recognizing INSL3 precursor failed to detect
the protein in the hypothalamus despite evident INSL3
expression in the gonad and pituitary, suggesting a low-
level or perhaps even no translation in this tissue. A
recent report in rats demonstrated that Leydig cells in
the testis could be the only source of circulating INSL3
[29]. It remains to be elucidated whether INSL3 pro-
duced in the pituitary contributes to circulating INSL3
in the rhesus macaque. It is noteworthy that the relative
intensities of INSL3 bands in the Western blot described
in the current study do not represent the relative abun-
dance of INSL3 in each tissue analyzed, because the
selective cell types expressing INSL3 may not distribute
evenly throughout the entire tissue (e.g., theca cells
surrounding antral follicles in the ovary) and only part
of each macaque tissue was used for protein extraction.
No specific antibodies against monkey INSL3 were avail-
able, so we tested several anti-human INSL3 antibodies
and eventually selected two different antibodies for their
optimal performance in Western blot and IHC. Human
INSL3 shares ~90% and ~60% identical amino acids
with macaque and mouse INSL3, respectively. The anti-
body used for Western blot was raised against a short
human INSL3 peptide that only differs in 2 amino acids
from mouse INSL3 precursor; thus, it is not surprising
that the antibody reacts with both monkey and mouse
INSL3.
Full-length macaque RXFP2 is transcribed in several
tissues including the hypothalamus, ovary and uterus. A
previous study showed that RXFP2 was expressed in the
testis but not in the ovary in humans [30]. The contra-
diction could be, at least in part, attributed to the selec-
tion of primers, i.e., while only full-length RXFP2
transcript was amplified by primers spanning between
exons 11 and 15 in our experiment, the amplification of
3’-UTR region of human RXFP2 would include various
spliced transcripts. Indeed, the identification of three
RXFP2 splice variants was previously reported in the
human uterus and adrenal glands [31], although only
one of the sequences, namely LGR8.1 which lacks
exon 11 of RXFP2, can be found in the GenBank
(AY899851.1). None of the three splice variants identi-
fied from the macaque corresponds exactly to LGR8.1,
although two of them (i.e., RXFP2-sv2 and RXFP2-sv3)
are missing exon 11. We noticed that the primers used
to amplify LGR8.1 s p a ne x o n s7 - 1 3o fh u m a nRXFP2,
which could explain why the primer pair failed to iden-
tify the missing exon 15 that was found in all three
splice variants reported in the current study. Unlike
LGR8.1 that can be translated into a truncated RXFP2
protein with partial leucine-rich repeat (LRR) region,
translation of all three RXFP2 splice variants identified
in the current study can cause early termination of the
full-length open reading frame (ORF) prior to the
seven-transmembrane (7TM) domain-coding region
(Figure 1b).
Within the ovary, INSL3 transcript and peptide are
predominantly expressed in the theca cells surrounding
antral follicles and weakly detectable in the corpus
luteum. This finding is similar to previous observations
in the cow [28] as well as in two other primate species,
marmoset monkeys and humans [16,17]. INSL3 was ori-
ginally demonstrated as a male hormone required for
testis positioning during fetal development [2,32,33]. A
previous finding showing that INSL3 was expressed in
the ruminant ovary at a much higher level than other
species was attributed to the natural loss of the gene for
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expressed in the primate ovary, even though relaxin
gene still exists in this species [35]. The function of
INSL3 in the female reproductive system has not been
well characterized. Besides the potential anti-apoptotic
role of INSL3 in the mouse ovary [36], Hsueh’sg r o u p
[3] reported that INSL3 could function as a local media-
tor for the mid-cycle LH surge and promote the oocyte
meiotic resumption through binding to RXFP2, an inhi-
bitory G (Gi) protein-coupled receptor (GPCR).
Although some recent evidence shows that the oocyte
maturation in response to LH may be independent of Gi
proteins [37], the highly enriched local INSL3 and the
presence of its receptor imply a possible local regulatory
role of the ligand-receptor in the ovary, especially during
preovulatory period. Notably, we did not detect RXFP2
transcript or protein in the germinal vesicle intact
oocyte, so any effect of INSL3 on maturation must be
mediated through the cumulus granulosa cells. More
functional studies in higher species will be required to
solve this puzzle. The failure of RXFP2 detection in the
ovary could be due to very low-level expression of
GPCRs in individual cells, the specificity of antibodies
applied, and/or an unknown nature of RXFP2 gene tran-
scription and translation. The presence of three differen-
tially spliced transcripts of RXFP2 in the ovary, and the
localization of full-length RXFP2 mRNA in granulosa
cells has not been previously reported. The majority of
primate genes produce splice variant transcripts [38]; it
is impossible to predict whether these splice variants
can actually be translated into proteins, whether these
proteins are functional, or whether these alternatively
spliced transcripts have a function independent of pro-
tein synthesis. However, since the reported splice var-
iants of RXFP2 encode truncated protein isoforms
without the seven-transmembrane domain, these protein
products are unlikely to function as GPCRs even if they
do exist [39,40]. It also remains to be determined
whether the cellular localization of full-length RXFP2
transcript in the ovary is specific to rhesus monkeys.
Conclusions
Taken together, we identified the INSL3-RXFP2 tran-
scripts and determined the tissue and cellular distribu-
tion of INSL3 in the ovary of rhesus macaque monkeys.
Despite the rapid increasing number of studies on this
newly identified ligand-receptor pair, the expression and
function of the system appear much more complex than
originally thought, especially in more advanced species.
Further biochemical and pharmacological studies in
nonhuman primates may eventually reveal the roles of
INSL3 and the significance of multiple splice variants of
RXFP2 in the ovary.
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